• Intermountain Health's AI Initiative and Regeneron's $100M Bet: Advancements in Health IT and Biomedicine

  • Apr 26 2024
  • Length: 5 mins
  • Podcast

Intermountain Health's AI Initiative and Regeneron's $100M Bet: Advancements in Health IT and Biomedicine

Listen for free

View show details

  • Summary

  • "AI in Life Sciences" dives into the world where technology and biology intersect, providing expert insight and analysis on the latest trends, breakthroughs, and controversies. In this episode, we explore a potential bird flu threat in Midwestern milk, the innovative use of AI in tackling workforce shortages in healthcare, and impressive revenue growth in AstraZeneca, thanks in part to their cancer drugs. We also discuss Regeneron Pharmaceuticals’ $100M wager on Mammoth’s CRISPR technology, the crucial role of AI understanding for health IT leaders, and how AI is revolutionizing drug discovery at AION Labs. Finally, we delve into Bristol Myers Squibb’s major restructuring and its implications for employees and the company's future growth. Stay tuned for these stories and more on "AI in Life Sciences".
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Intermountain Health's AI Initiative and Regeneron's $100M Bet: Advancements in Health IT and Biomedicine

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available